SooR.KimMD

PubMed

• Tuning structural durability of yeast-encapsulating alginate gel beads with interpenetrating networks for sustained bioethanol production.
  Cha, C., Kim, S.R., Jin, Y., Kong, H.> ;Biotechnol Bioeng. 2012 Jan
• Co-fermentation of cellobiose and galactose by an engineered Saccharomyces cerevisiae.
  Ha, S., Wei, Q., Kim, S.R., Galazka, J.M., Cate, J., Jin, Y.> ;Appl Environ Microbiol. 2011 Aug 15
• Xylitol does not inhibit xylose fermentation by engineered Saccharomyces cerevisiae expressing xylA as severely as it inhibits xylose isomerase reaction in vitro.
  Ha, S., Kim, S.R., Choi, J., Park, M.S., Jin, Y.> ;Appl Microbiol Biotechnol. 2011 Oct
• Engineered Saccharomyces cerevisiae capable of simultaneous cellobiose and xylose fermentation.
  Ha, S., Galazka, J.M., Kim, S.R., Choi, J., Yang, X., Seo, J., Glass, N.L., Cate, J.D., Jin, Y.> ;Proc Natl Acad Sci U S A. 2011 Jan 11
• Efficacy and safety of double filtration plasmapheresis in combination with interferon therapy for chronic hepatitis C.
  Kaneko, S., Sata, M., Ide, T., Yamashita, T., Hige, S., Tomita, E., Mochida, S., Yamashita, Y., Inui, Y., Kim, S.R., Komada, N., Mikami, T., Satoh, S., Morita, S., Tak...> ;Hepatol Res. 2010 Nov
• Well-differentiated hepatocellular carcinoma smaller than 15 mm in diameter totally eradicated with percutaneous ethanol injection instead of radiofrequency ablation.
  Kim, S.R., Imoto, S., Nakajima, T., Ando, K., Mita, K., Taniguchi, M., Sasase, N., Matsuoka, T., Kudo, M., Hayashi, Y.> ;Hepatol Int. 2009-06-01
• Acute Pancreatitis Associated with Pegylated Interferon and Ribavirin Treatment of Chronic Hepatitis C, Genotype 1b with High Viral Load.
  Ando, K., Kim, S.R., Imoto, S., Nakajima, T., Mita, K., Fukuda, K., Taniguchi, M., Sasase, N., Muramatsu, A., Matsuoka, T., Kudo, M., Hayashi, Y.> ;Case Rep Gastroenterol. 2009
• Utility of Gd-EOB-DTPA-Enhanced MRI in Diagnosing Small Hepatocellular Carcinoma.
  Kim, S.R., Imoto, S., Nakajima, T., Ando, K., Mita, K., Fukuda, K., Nishikawa, R., Koma, Y., Matsuoka, T., Kudo, M., Hayashi, Y.> ;Case Rep Gastroenterol. 2009
• Blood cell, liver function, and response changes by PEG-interferon-alpha2b plus ribavirin with polaprezinc therapy in patients with chronic hepatitis C.
  Kim, K.I., Kim, S.R., Sasase, N., Akimoto, Y., Shikata, M., Ohtani, A., Hirooka, T., Tanaka, K.> ;Hepatol Int. 2008-03-01
• Hypervascular liver nodules in heavy drinkers of alcohol.
  Kim, S.R., Maekawa, Y., Imoto, S., Sugano, M., Kudo, M.> ;Alcohol Clin Exp Res. 2004 Aug
• Expression of progenitor cell markers in livers with fulminant massive necrosis.
  Seki, S., Kitada, T., Sakaguchi, H., Iwai, S., Kawada, N., Hayashi, Y., Kim, S.R.> ;Hepatol Res. 2003 Feb
• CEA producing primary hepatic carcinoid.
  Kim, S.R., Imoto, S., Maekawa, Y., Matsuoka, T., Hayashi, Y., Ando, K., Mita, K., Shintani, S., Kim, H.B., Ku, K., Koterazawa, T., Fukuda, K., Yano, Y., Nakaji, M., Ik...> ;Hepatol Res. 2002 Apr
• Real-time quantitative polymerase chain reaction for MDR1, MRP1, MRP2, and CYP3A-mRNA levels in Caco-2 cell lines, human duodenal enterocytes, normal colorectal tissue...
  Nakamura, T., Sakaeda, T., Ohmoto, N., Tamura, T., Aoyama, N., Shirakawa, T., Kamigaki, T., Nakamura, T., Kim, K.I., Kim, S.R., Kuroda, Y., Matsuo, M., Kasuga, M., Oku...> ;Drug Metab Dispos. 2002 Jan
• Join now to see all